Day: June 27, 2022

  Paris, June 27, 2022,   Disclosure of Transactions in Own Shares   In accordance with the authorization given by the shareholders’ annual meeting on July 6, 2021 to trade on its own shares and pursuant to applicable law on share repurchase, Kering (LEI: 549300VGEJKB7SVUZR78) declares the following purchases of its own shares (FR0000121485) from June 20 to 24, 2022:  Issuer’s name Issuer’s identifying code Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares Market (MIC code)KERING 549300VGEJKB7SVUZR78 20/06/2022 FR0000121485 14 352 485.5973 XPARKERING 549300VGEJKB7SVUZR78 20/06/2022 FR0000121485 7 398 484.6121 CEUXKERING 549300VGEJKB7SVUZR78 22/06/2022 FR0000121485...

SHANGHAI, China, June 27, 2022 (GLOBE NEWSWIRE) — Hywin Holdings Ltd. (“Hywin Wealth”, “Hywin”, or the “Company”) (NASDAQ: HYW), a leading independent wealth management service provider in China, today announced that Mr. Vincent Chun Hung Chan has been appointed to its Board of Directors, effective June 27, 2022. Mr. Vincent Chun Hung Chan will be serving as an independent non-executive director of the Company. With over 28 years of experience in private equity in Asia, Mr. Chan has been the Director of Samena Capital, which principally engages in private equity investment, since March 2021 and was a Senior Managing Director and Head of Asia of Samena Capital from 2016 to 2021. From 1991 to 2016, he served several leading private equity investment companies including HSBC Equity Management Limited, Suez...

Innovative Transseptal Access System Is First and Only to Feature Integrated Dilator and Needle to Reduce Exchanges CARLSBAD, Calif., June 27, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the commercial launch of an expanded suite of left-heart access products to now include the AcQCross™ Qx system for use with the TruSeal (TM) and FXD(TM) delivery system for the Watchman™ LAAC Device. Gaining access to the left atrium requires physicians to cross the septum, a multi-step process that often involves the exchange of wires and needles while trying to achieve the proper angle and location on the septum. AcQCross is the first and only transseptal system engineered with an integrated...

ADELAIDE, Australia, June 27, 2022 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today announced that Dr. Errol De Souza, Executive Chairman of Bionomics, will participate in a fireside chat at the First Annual H.C. Wainwright Mental Health Conference taking place virtually and in-person in New York on June 27, 2022. An audio webcast link for the event, when available, will be posted to Bionomics’ website in the Investors-Events and Presentations section. FOR FURTHER INFORMATION PLEASE CONTACT:Investor RelationsMr. Connor BernsteinVice President, Strategy and...

End-of-phase 1 meeting with the U.S. Food and Drug Administration (FDA) resulted in alignment on the design of a single arm trial for pan-FGFR (FGFRi) treatment-naïve FGFR2-fusion cholangiocarcinoma (CCA) to potentially support accelerated approval Interim data from the once daily (QD) dosing schedule shared with the FDA demonstrated confirmed partial responses in eight out of thirteen (62%) FGFRi-naïve FGFR2-fusion CCA patients, including all four of the patients treated at the registrational trial dose of 70 mg QD Relay Therapeutics discloses three new programs as part of a growing HR+/HER2- breast cancer franchise: selective CDK2 inhibitor, ERα degrader, and chemically distinct pan mutant-PI3Kα (RLY-5836) Relay Therapeutics continues to expect its current cash, cash equivalents and investments will be sufficient to fund its current...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR TO ANY U.S. PERSON (AS DEFINED BELOW) OR IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 (“MAR”). 27 June 2022 MAXIMA GRUPĖ, UAB ANNOUNCES TENDER OFFER TO PURCHASE NOTES FOR CASH Maxima Grupė, UAB (the “Issuer“) announces...

EDMONTON, Alberta, June 27, 2022 (GLOBE NEWSWIRE) — Mineworx Technologies Ltd., (the “Corporation” or “Mineworx“) (TSXV: MWX) (OTCQB: MWXRF) (FSE: YRS WKN: A2DSW3) is pleased to announce that it has successfully completed the Optimization stage of testing in Tennessee. This testing provided the required information to move forward with the next phase of the Catalytic Converter project. The results obtained has indicated that the commercial production facility will be designed based on a modular concept. Final design protocols are underway and when completed will initiate the procurement process for Module 1. The minimum production output for this module is expected to be approximately 2.5 tonnes per day and further information on the expected operational performance will be disclosed upon the completion...